| Product Code: ETC10656559 | Publication Date: Apr 2025 | Updated Date: Nov 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Bhawna Singh | No. of Pages: 65 | No. of Figures: 34 | No. of Tables: 19 |
In 2024, Israel continued to rely on imports of metoprolol succinate from various countries including Switzerland, UK, Belgium, USA, and Germany. The market concentration, as measured by HHI, remained low, indicating a diverse import market. However, the compound annual growth rate (CAGR) for the period 2020-2024 was negative at -2.14%, with a slight decline in growth rate from 2023 to 2024. This data suggests a stable but slow-moving market for metoprolol succinate imports in Israel.

1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Israel Metoprolol Succinate Market Overview |
3.1 Israel Country Macro Economic Indicators |
3.2 Israel Metoprolol Succinate Market Revenues & Volume, 2021 & 2031F |
3.3 Israel Metoprolol Succinate Market - Industry Life Cycle |
3.4 Israel Metoprolol Succinate Market - Porter's Five Forces |
3.5 Israel Metoprolol Succinate Market Revenues & Volume Share, By Dosage Form, 2021 & 2031F |
3.6 Israel Metoprolol Succinate Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.7 Israel Metoprolol Succinate Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
3.8 Israel Metoprolol Succinate Market Revenues & Volume Share, By End User, 2021 & 2031F |
4 Israel Metoprolol Succinate Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of cardiovascular diseases in Israel |
4.2.2 Growing awareness about the benefits of metoprolol succinate in managing heart conditions |
4.2.3 Technological advancements leading to the development of improved formulations of metoprolol succinate |
4.3 Market Restraints |
4.3.1 Stringent regulatory requirements for the approval and commercialization of pharmaceutical products |
4.3.2 Competition from alternative medications for heart conditions in the Israeli market |
5 Israel Metoprolol Succinate Market Trends |
6 Israel Metoprolol Succinate Market, By Types |
6.1 Israel Metoprolol Succinate Market, By Dosage Form |
6.1.1 Overview and Analysis |
6.1.2 Israel Metoprolol Succinate Market Revenues & Volume, By Dosage Form, 2021 - 2031F |
6.1.3 Israel Metoprolol Succinate Market Revenues & Volume, By Tablets, 2021 - 2031F |
6.1.4 Israel Metoprolol Succinate Market Revenues & Volume, By Extended-Release Tablets, 2021 - 2031F |
6.1.5 Israel Metoprolol Succinate Market Revenues & Volume, By Capsules, 2021 - 2031F |
6.1.6 Israel Metoprolol Succinate Market Revenues & Volume, By Others, 2021 - 2031F |
6.2 Israel Metoprolol Succinate Market, By Application |
6.2.1 Overview and Analysis |
6.2.2 Israel Metoprolol Succinate Market Revenues & Volume, By Hypertension, 2021 - 2031F |
6.2.3 Israel Metoprolol Succinate Market Revenues & Volume, By Angina Pectoris, 2021 - 2031F |
6.2.4 Israel Metoprolol Succinate Market Revenues & Volume, By Heart Failure, 2021 - 2031F |
6.2.5 Israel Metoprolol Succinate Market Revenues & Volume, By Others, 2021 - 2031F |
6.3 Israel Metoprolol Succinate Market, By Distribution Channel |
6.3.1 Overview and Analysis |
6.3.2 Israel Metoprolol Succinate Market Revenues & Volume, By Hospital Pharmacies, 2021 - 2031F |
6.3.3 Israel Metoprolol Succinate Market Revenues & Volume, By Retail Pharmacies, 2021 - 2031F |
6.3.4 Israel Metoprolol Succinate Market Revenues & Volume, By Online Pharmacies, 2021 - 2031F |
6.3.5 Israel Metoprolol Succinate Market Revenues & Volume, By Others, 2021 - 2031F |
6.4 Israel Metoprolol Succinate Market, By End User |
6.4.1 Overview and Analysis |
6.4.2 Israel Metoprolol Succinate Market Revenues & Volume, By Hospitals, 2021 - 2031F |
6.4.3 Israel Metoprolol Succinate Market Revenues & Volume, By Clinics, 2021 - 2031F |
6.4.4 Israel Metoprolol Succinate Market Revenues & Volume, By Homecare Settings, 2021 - 2031F |
6.4.5 Israel Metoprolol Succinate Market Revenues & Volume, By Others, 2021 - 2031F |
7 Israel Metoprolol Succinate Market Import-Export Trade Statistics |
7.1 Israel Metoprolol Succinate Market Export to Major Countries |
7.2 Israel Metoprolol Succinate Market Imports from Major Countries |
8 Israel Metoprolol Succinate Market Key Performance Indicators |
8.1 Number of new prescriptions of metoprolol succinate by healthcare providers |
8.2 Patient adherence rates to metoprolol succinate treatment regimens |
8.3 Number of clinical trials evaluating the efficacy and safety of metoprolol succinate in Israel |
9 Israel Metoprolol Succinate Market - Opportunity Assessment |
9.1 Israel Metoprolol Succinate Market Opportunity Assessment, By Dosage Form, 2021 & 2031F |
9.2 Israel Metoprolol Succinate Market Opportunity Assessment, By Application, 2021 & 2031F |
9.3 Israel Metoprolol Succinate Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
9.4 Israel Metoprolol Succinate Market Opportunity Assessment, By End User, 2021 & 2031F |
10 Israel Metoprolol Succinate Market - Competitive Landscape |
10.1 Israel Metoprolol Succinate Market Revenue Share, By Companies, 2024 |
10.2 Israel Metoprolol Succinate Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here